Sinobiopharma, Inc. reported its most important product, the skeletal muscle relaxant KuTai (Cisatracurium Besylate), is now covered by China’s major insurance plan, the National Basic Medical Insurance, Employment Injury Insurance and Maternity Insurance (2009 Edition). The company recently reported that KuTai accounts for 96% of its revenues. More details...

Stock Symbol: (OTCBB: SNBP)